21028 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
METHODS AND MATERIALS FOR TREATING OSTEOARTHRITIS
#602METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM, ARDS, AND ACUTE LUNG INJURY USING BETA-GLUCOCEREBROSIDASE
#603TREATMENT FOR BK POLYOMAVIRUS INFECTION
#604FEED SUPPLEMENTS
#605Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
#606ENZYMATIC REPLACEMENT THERAPY AND ANTISENSE THERAPY FOR POMPE DISEASE
#607Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage disorders
#608Nanostructure lipid system
#609Amino-reactive positively charged ATRP initiators that maintain their positive charge during synthesis of biomacro-initiators
#610Compositions and Methods for Reducing Atmospheric Methane and Nitrous Oxide Emissions
#611Enzymes and methods for cleaving n-glycans from glycoproteins
#612Reducing or inhibiting ocular damage by hyaluronidase administration
#613Proteins having pneumococcal capsule degrading activity and methods of use
#614Lipid nanoparticle compositions and methods for mRNA delivery
#615USE OF LOW pH ACTIVE ALPHA-1,4;/1,6-GLYCOSIDE HYDROLASES (GLCH) AS A FEED ADDITIVE FOR RUMINANTS TO ENHANCE STARCH DIGESTION
#616CONTACT LENS USE IN THE TREATMENT OF AN OPHTHALMOLOGIC CONDITION
#617TAILORING SITE SPECIFICITY OF BIOCONJUGATION USING STEP-WISE ATRP ON PROTEINS
#618PH20 polypeptide variants, formulations and uses thereof
#619Conjugates of biologically active molecules to functionalized polymers
#620PH20 polypeptide variants, formulations and uses thereof
#621TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)
#622METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS
#623Augmented acid alpha-glucosidase for the treatment of Pompe disease
#624GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#625Methods for treating neurological symptoms associated with lysosomal storage diseases
#626Methods and compositions for the treatment of steatosis-associated disorders
#627Human alpha-galactosidase variants
#628Compositions and methods for treating Pompe disease
#629Endolysins active against bacteria, pharmaceutical compositions, and methods relating thereto
#630Particles for delivery of proteins and peptides
#631TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G
#632Methods and compositions related to physiologically responsive microneedle delivery systems
#633GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL
#634Hyaluronidase compositions and methods of using same for determining the etiology of peri-orbital puffiness
#635INTRAVENTRICULAR ENZYME DELIVERY FOR LYSOSOMAL STORAGE DISEASES
#636SUBCUTANEOUSLY ADMINISTERED ANTI-IL-6 RECEPTOR ANTIBODY
#637VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#638Subcutaneous Delivery of Messenger RNA
#639Engineering of DNASE enzymes for manufacturing and therapy
#640Method for treating subject suffering from flavivirus infection
#641Neuraminidase inhibition to improve glycocalyx volume and function to ameliorate cardiovascular diseases in pathologies associated with glycocalyx damage
#642STRUCTURE, MANUFACTURING AND USES OF HUMAN-DERIVED CELL-PERMEABLE PEPTIDES CONJUGATED WITH SPECIFIC BIOLOGICALLY ACTIVE CARGO PEPTIDES
#643Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
#644Treatment of Glycogen Storage Disease Type II
#645Compositions and methods comprising lysin PlyCP025 and derivatives thereof
#646HOMOVANILLYL ALCOHOL (HVA), HVA ISOMER, METHODS OF MAKING COMPOSITIONS COMPRISING SUCH COMPOUNDS, AND METHODS USING SUCH COMPOUNDS
#647METHODS OF TREATING BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
#648Hyaluronidase compositions and methods of using same for assessing and/or treating periorbital puffiness
#649Method of Treating a Disorder of Cognitive Performance or Memory
#650Periorbital puffiness assessment scale and methods of use thereof
#651Animal Feed Compositions and Uses Thereof
#652METHOD OF TREATING SCHIZOPHRENIA OR SCHIZOPHRENIFORM DISORDER
#653Lactase bulk powder and lactase preparation
#654Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#655GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#656Development of amyloglucosidase as a medicinal food or dietary supplement
#657SILK-BASED PRODUCTS AND METHODS OF USE
#658Soluble bacterial and fungal proteins and methods and uses thereof in inhibiting and dispersing biofilm
#659Endolysin polypeptide
#660CHITINASE ADMINISTRATION TO THE AIRWAY TO TREAT INFLAMMATION AND AGE-RELATED PULMONARY FIBROSIS
#661BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#662Poloxamer compositions with reduced sol-gel transition temperatures and methods of reducing the sol-gel transition temperature of poloxamer compositions
#663NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME
#664TREATMENT OF GAUCHER DISEASE
#665EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#666Subcutaneous formulations of anti-CD38 antibodies and their uses
#667TREATMENT OF MICROBIAL INFECTIONS
#668GNE as a therapeutic agent
#669Subcutaneous formulations of anti-CD38 antibodies and their uses
#670ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM
#671METHODS TO TREAT POMPE DISEASE USING A RECOMBINANT ADENO-ASSOCIATED VIRUS
#672Identification of lysins and derivatives thereof with bactericidal activity against
#673SUBCUTANEOUS HER2 ANTIBODY FORMULATIONS
#674NOVEL ARTIFICIAL TEARS CONTAINING RECOMBINANT HUMAN LYSOZYME AND RECOMBINANT HUMAN EGF
#675Methods and compositions for improved cognition
#676Lysosomal Targeting Peptides and Uses Thereof
#677NOVEL SIALIDASES AND USES THEREOF
#678Lipid nanoparticle compositions and methods for mRNA delivery
#679CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#680HIGHLY CONCENTRATED PHARMACEUTICAL FORMULATIONS
#681COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#682FORMULATION OF GLUCOSINOLATES AND MYROSINASE
#683Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients
#684Method for Delivering Drug to Muscle
#685Animal feed compositions and methods of use
#686POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF PROTEIN THERAPEUTICS
#687Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide
#688ANIMAL CELL STRAIN AND METHOD FOR USE IN PRODUCING GLYCOPROTEIN, GLYCOPROTEIN AND USE THEREOF
#689ENZYME REPLACEMENT THERAPY FOR MUCOPOLYSACCHARIDOSIS IIID
#690Ionizable cationic lipids
#691COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM
#692BACTERIOPHAGE LYSIN AND ANTIBIOTIC COMBINATIONS AGAINST GRAM POSITIVE BACTERIA
#693Biomarkers of methotrexate-induced immune tolerance
#694COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE
#695Use of direct-fed microbials in preventing and/or treating -based infections in animals
#696Anti-CD38 antibodies for treatment of light chain amyloidosis and other CD38-positive hematological malignancies
#697Human alpha-galactosidase variants
#698Methods and compositions for CNS delivery of arylsulfatase A
#699Methods for the Use of Low-Dose Immune Modulators Transiently for Treating Patients Undergoing Protein Replacement Therapy
#700Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
#701COMPOSITIONS, SYSTEMS, AND METHODS FOR SCAR TISSUE MODIFICATION
#702COMPOSITIONS AND METHODS FOR TREATING MPSI
#703Treatment of Middle East respiratory syndrome coronavirus
#704ENZYMATIC MODIFICATION OF ANTI-AQP4 AUTOANTIBODY FOR MODULATING NEUROMYELITIS OPTICA
#705ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE
#706Viral treatment
#707MULTISPECIFIC MOLECULES COMPRISING A NON-IMMUNOGLOBULIN HETERODIMERIZATION DOMAIN AND USES THEREOF
#708LOCAL AND REGIONAL ANESTHESIA AND ANALGESIA
#709Lysin polypeptides active against Gram-negative bacteria
#710MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#711WIDE-SPECTRUM ANTIBACTERIAL PHARMACEUTICAL FORMULATIONS COMPRISING LYSOZYME AND METHODS OF USING THE SAME
#712Process for preparing a drug delivery composition
#713MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS
#714Compositions having antifungal activity
#715Human alpha-galactosidase variants
#716Human alpha-galactosidase variants
#717TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE OR PREVENT ANAPHYLAXIS IN RESPONSE TO A NON-ALLERGENIC ANTIGEN
#718Compositions and methods for treatment of GCASE related disease states
#719Use of isothiocyanate in smokeless tobacco products
#720Conjugates of tumor necrosis factor inhibitors to functionalized polymers
#721COMBINED THERAPEUTIC USE OF ANTIBODIES AND IMMUNOGLOBULIN G-DEGRADING ENZYMES
#722Enzymes and methods for cleaving n-glycans from glycoproteins
#723Subcutaneous formulations of anti-CD38 antibodies and their uses
#724Lipid nanoparticle compositions and methods for mRNA delivery
#725Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
#726COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND FOR THE ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES
#727COMPOSITION OF PROBIOTICS AND DIGESTIVE ENZYMES AND METHOD OF PREPARING AND USING THE SAME
#728HYALINE CARTILAGE SHAPING
#729PH20 polypeptide variants, formulations and uses thereof
#730Compositions and methods for treating age-related diseases
#731Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone
#732FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE
#733Method and composition for therapeutic management of gluten intolerance
#734Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
#735Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone
#736Method of treating glycogen storage disease type VI
#737Method and carrier complexes for delivering molecules to cells
#738Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#739Methods and Compositions for the Prevention and Treatment of Influenza
#740SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF
#741COMPOSITIONS AND METHODS FOR SUPPRESSION OF INHIBITOR FORMATION AGAINST COAGULATION FACTORS IN HEMOPHILIA PATIENTS
#742Dosing Regimens For The Treatment Of Fabry Disease
#743HYDROPHOBIC ION PAIRING AND FLASH NANOPRECIPITATION FOR FORMATION OF CONTROLLED-RELEASE NANOCARRIER FORMULATIONS
#744GLYCOSIDASE REGIMEN FOR TREATMENT OF INFECTIOUS DISEASE
#745Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder
#746Method of preventing aggravation of a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor
#747Therapeutic and prophylactic treatment for colorectal cancer
#748Bioconversion of oleuropein
#749PH20 polypeptide variants, formulations and uses thereof
#750Combined Multistage Microbial Preparations and Method of Their Application
#751Method for the treatment of mucopolysaccharidosis type I
#752Method for enhancing folding and transport of misfolded glucocerebrosidase
#753METHODS AND COMPOSITIONS FOR THE TREATMENT OF FABRY DISEASE
#754VACCINES INTELLIGENTLY PRODUCED BY EPITOPE RECOMBINATION (VIPER) FOR INFLUENZA
#755Cleavable lipids
#756Methods and compositions for the treatment of lysosomal storage diseases
#757Subcutaneous formulations of anti-CD38 antibodies and their uses
#758ANIMAL FEED COMPOSITIONS AND METHODS OF USE
#759Methods and compositions for improved cognition
#760Methods and compositions for treatment of glycogen storage diseases and glycogen metabolism disorders
#761Conjugates of biologically active molecules to functionalized polymers
#762TREATMENT OF MERKEL CELL POLYOMAVIRUS INFECTION
#763COMPOSITIONS AND METHODS FOR INCREASING PHYTOCHEMICAL BIOAVAILABLITY AND BIOACTIVITY
#764Phosphoserine containing compositions for immune tolerance induction
#765COMPOSITION CONTAINING DIGESTIVE ENZYMES AND NUTRIENTS SUITABLE FOR ENTERAL ADMINISTRATION
#766ANTIBACTERIAL METHODS AND RELATED KITS
#767AN AGENT, A DEVICE AND A BLOOD-CIRCULATION SYSTEM FOR TREATING LYSOSOMAL STORAGE DISEASES, AND A METHOD FOR TREATING LYSOSOMAL STORAGE DISEASES
#768Method for synthesis of protein amphiphiles
#769Technology for Preparation of Macromolecular Microspheres
#770USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES
#771High concentration alpha-glucosidase compositions for the treatment of Pompe disease
#772Methods and compositions to prevent and treat inflammation and allergic reactions
#773Recombinant klotho proteins and compositions and methods involving same
#774METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
#775Formulations comprising recombinant acid alpha-glucosidase
#776INHIBITION OF VASCULAR ENDOTHELIAL CELL-MEDIATED PHAGOCYTIC PROCESSES FOR TREATMENT OF DEMYELINATING CONDITIONS
#777TREATMENT OF HUMAN METAPNEUMOVIRUS
#778Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#779Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
#780Stable Bioactive Substances and Methods of Making
#781Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease
#782lysins for detection and treatment of gram positive bacteria
#783Disulfide bond stabilized polypeptide compositions and methods of use
#784AAV9-mediated gene therapy for treating mucopolysaccharidosis type I
#785Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
#786Composition and method for promoting reduction of heat stress in animals
#787BIOMARKERS OF PROTEOPATHIES AND USES THEREOF
#788Use of Hsp70 as a regulator of enzymatic activity
#789Method of Providing Subcutaneous Administration of Anti-CD38 Antibodies
#790PHARMACEUTICAL COMBINATION FOR TREATMENT OF FABRY DISEASE AND USE THEREOF
#791Manufacturing and engineering of DNASE enzymes for therapy
#792Anti-CD28 Humanized Antibodies Formulated for Administration to Humans
#793CNS delivery of therapeutic agents
#794Use of HSP70 as a regulator of enzymatic activity
#795METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE
#796HYPOTONIC COMPOSITION FOR FAT DECOMPOSITION AND METHOD FOR PREPARING SAME
#797Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
#798Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#799COMPOSITIONS AND COMBINATIONS FOR USE AS FOOD SUPPLEMENTS FOR ANIMALS
#800METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#801Selective recovery
#802LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#803HEAT SHOCK PROTEIN INDUCERS AND FRONTOTEMPORAL DISORDERS
#804COMPOSITIONS AND METHODS TO PREVENT AND TREAT BIOFILMS
#805Methods for the use of low-dose immune modulators transiently for treating patients undergoing protein replacement therapy
#806Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity
#807Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase
#808Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activity
#809Cosmetic compositions for skin health and methods of using same
#810METHODS COMPRISING DOSING COMBINATIONS FOR REDUCING UNDESIRED HUMORAL IMMUNE RESPONSES
#811METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#812GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
#813Methods and compositions for CNS delivery of iduronate-2-sulfatase
#814Compounds, devices, and uses thereof
#815Microorganisms and methods for producing biologics and introducing biologics to sites
#816Enzymes and methods for cleaving N-glycans from glycoproteins
#817Water resistant enhanced wound healing film and preparation method thereof
#818Efficient aqueous encapsulation and controlled release of bioactive agents
#819Glycoside hydrolases to treat biofilm-associated infections
#820TREATMENT FOR BK POLYOMAVIRUS INFECTION
#821Oligosaccharides comprising an aminooxy group and conjugates thereof
#822Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#823Conjugates of tumor necrosis factor inhibitors to functionalized polymers
#824GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#825bacteriophage lysins for detection and treatment of gram positive bacteria
#826Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses
#827Compositions and methods to prevent and treat biofilms
#828Acid-alpha glucosidase variants and uses thereof
#829Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
#830Biofilm prevention, disruption and treatment with bacteriophage lysin
#831Enzymes and methods for cleaving N-glycans from glycoproteins
#832Compositions and methods for promoting a healthy microbial flora in a mammal
#833COMPOSITION AND METHOD FOR CO-ADMINISTRATION WITH A GROWTH PROMOTANT
#834Combination treatment for atopic dermatitis
#835Feed additive formulation and methods of making and using the same
#836Composition for the treatment of gastrointestinal disorders
#837Contact lens use in the treatment of an ophthalmologic condition
#838Highly concentrated pharmaceutical formulations
#839NOVEL RECOMBINANT EXOSOME CONTAINING HYALURONIDASE AND USE THEREOF
#840TREATMENT OF MUCOPOLYSACCHARIDOSIS I WITH FULLY-HUMAN GLYCOSYLATED HUMAN ALPHA-L-IDURONIDASE (IDUA)
#841Recombinant α-galactosidase A for treatment of Fabry disease
#842Implantable device for sustained release of a macromolecular drug compound
#843ENZYMATIC MODIFICATION OF ANTI-AQP4 AUTOANTIBODY FOR MODULATING NEUROMYELITIS OPTICA
#844Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
#845METHODS OF SELECTING SUBJECTS FOR COMBINATION CANCER THERAPY WITH A POLYMER-CONJUGATED SOLUBLE PH20
#846USE OF VIRAL VECTORS IN THE TREATMENT OF RETINOBLASTOMA
#847Adeno-associated virus vectors encoding modified G6PC and uses thereof
#848Acinetobacter lysins
#849MODIFIED HYALURONIDASES AND USES IN TREATING HYALURONAN-ASSOCIATED DISEASES AND CONDITIONS
#850SYNTHETIC BACTERIA AND METHODS OF USE
#851TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION
#852Subcutaneous formulations of anti-CD38 antibodies and their uses
#853Materials and methods useful for treating glioblastoma
#854Compositions and methods for inhibiting biofilm deposition and production
#855Peptide-Mediated Non-Covalent Delivery of Active Agents Across the Blood-Brain Barrier
#856Lipid nanoparticle compositions and methods for mRNA delivery
#857Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
#858Pharmaceutical Compositions Containing Cannabis, Uses Thereof and Methods for Improving Digestion and/or Treating Symptoms Associated with Gastrointestinal Complications
#859Cleavable lipids
#860Enzyme-rich malt extract (ERME) formulations
#861Vasoconstrictive and antibacterial combination treatment for rosacea
#862ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM
#863Subcutaneous delivery of messenger RNA
#864Animal feed compositions and uses thereof
#865Selective recovery
#866Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
#867Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#868Use of hyaluronidase for treatment of muscle stiffness
#869STAPHTAME ACTIVITY ON BIOFILMS
#870Local orbital therapy for thyroid eye disease
#871Methods of treating celiac disease
#872PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN
#873METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OTHER NEUROLOGICAL DISORDERS
#874Viscosity-reducing excipient compounds for protein formulations
#875Antimicrobial compositions and methods employing same
#876TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
#877Treatment of α-galactosidase a deficiency
#878CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#879Pharmaceutical composition containing a mixture of proenzymes and enzymes
#880Egg protein formulations and methods of manufacture thereof
#881Subcutaneously administered anti-IL-6 receptor antibody
#882Engineered target specific nucleases
#883METHODS FOR TREATING FARBER DISEASE
#884Modified hyaluronic acid hydrogels and proteins for the time-controlled release of biologic agents
#885Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
#886Treatment and/or prevention of sepsis
#887Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#888Treatment of Fabry disease
#889Therapeutic agent for disc herniation
#890Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
#891PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING LACTASE AND PROCESS FOR PRODUCING SAME
#892Targeted Therapeutic Proteins
#893Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders
#894Composition comprising pollen and/or pistil extracts, preparation process and associated uses
#895METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS
#896Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof
#897Antimicrobial agents
#898METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME
#899SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER
#900Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients